• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

FDA clears iPhone app for the Insulet Omnipod 5

October 23, 2023 By Sean Whooley

Insulet Omnipod 5 Dexcom G6
Insulet’s Omnipod 5 with the Dexcom G6 CGM. [Image from Insulet]
Insulet (Nasdaq:PODD) announced today that the FDA granted 510(k) clearance for its Omnipod 5 App for iPhone.

Clearance makes Insulet the only company offering a tubeless, automated insulin delivery (AID) system with full control from a compatible Android and iOS smartphone. The company first launched the system, compatible with Android devices, in August 2022.

Insulet Chief Technology Officer Mark Field said last week that the company believed this regulatory nod would come imminently. Presenting during a session at DeviceTalks West in Santa Clara, California, Field explained how Insulet brought Omnipod 5 to market.

“Today, we celebrate this significant milestone in our ongoing effort to provide people with diabetes solutions that improve their lives and help them think less about diabetes,” said Eric Benjamin, EVP, chief product & customer experience officer. “We are thrilled to add the iOS platform to our mobile app offerings and elevate Omnipod 5’s market-leading position in phone-controlled AID systems.”

Insulet can now offer users controllability of their Omnipod 5 from their compatible iPhone. It gives them more options for those who prefer not to carry an extra device, as Insulet offers its own controller.

The Omnipod 5 App for iPhone delivers the same functionality as the Android app, the company said. It also has additional capabilities and an intuitive design. Users can access a new custom foods feature and safe carbohydrate data for favorite foods, snacks or meals consumed frequently.

Insulet plans to launch its iPhone app first with Dexcom G6 continuous glucose monitor (CGM) integration. It expects a full market release in 2024 and users can download the iPhone app free of charge once available.

The analyst’s view on the latest good news from Insulet

BTIG analysts Marie Thibault and Sam Eiber responded to the news by maintaining their “Buy” rating for Insulet.

“This is a significant win in our view, since it enables a more convenient patient experience by removing the need to carry a separate controller,” they wrote. “Patients using the app will also have access to a new custom foods feature with the ability to save carbohydrate data for favorite foods or meals that are consumed frequently.”

The analysts made no changes to their estimates for Insulet. They plan to have more on the company when it reports its third-quarter financial results on Nov. 2.

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Patient Monitoring, Regulatory/Compliance, Technology Tagged With: FDA, Insulet

IN CASE YOU MISSED IT

  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Diabeloop launches insulin delivery algorithm in Germany
  • GlucoModicum has positive data for needle-free CGM
  • Lifecare takes next steps in CGM implant development
  • Ypsomed brings autoinjector for dual GCG/GLP-1 delivery to China

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS